In a cancer context, silencing of syndecan-4 expression was shown to exhibit an antitumoral effect on human papillary thyroid carcinoma cells by affecting apoptosis and epithelial-to-mesenchymal transition via the Wnt/beta-catenin pathway [23]. This evidence concerns the gene SDC4 and differentiated thyroid carcinoma.